HbA1c levels

Related by string. HbA 1c levels * HbA 1c . HbA 1C . Hb A1C . Hb A1c . HbA1C : hemoglobin A1c HbA1c . baseline HbA1c . Hemoglobin A1c HbA1c . hemoglobin A1C HbA1C . glycosylated hemoglobin HbA1c . HbA1C levels / leveled . leveling . Levels . leveler . Level . LEVEL : Level Cloud Computing . Service Level Agreements . blood glucose levels . REACHES INITIAL RESISTANCE LEVEL . troop levels * *

Related by context. All words. (Click for frequent words.) 81 A1C levels 80 HbA1c 78 HbA 1c 77 hemoglobin A1c levels 77 HbA 1c levels 76 A1c levels 76 hemoglobin A1c HbA1c 75 baseline HbA1c 75 HbA1C levels 75 HbA1C 75 glycated hemoglobin levels 74 fasting plasma glucose 74 systolic BP 74 Hb A1C 73 A1C 73 fasting blood glucose 73 A1c 72 hemoglobin A1C 72 antihypertensive medications 72 glycosylated hemoglobin HbA1c 72 NPH insulin 71 fasting glucose levels 71 hemoglobin A1c 71 glycated hemoglobin 71 glycated hemoglobin HbA1c 70 serum phosphorus 70 serum creatinine levels 70 glycosylated hemoglobin 70 triglyceride levels 70 serum urate 70 sUA 70 blood glucose levels 70 fasting glucose 70 baseline A1C 70 insulin detemir 70 serum uric acid 69 fasting plasma glucose FPG 69 fasting insulin 69 LVEF 69 lispro 69 nondiabetic patients 69 platelet reactivity 69 MMSE scores 69 HOMA IR 68 serum potassium 68 serum calcium levels 68 mL/min/#.# m 2 68 glycemia 68 mmol l 68 mg dL 68 lowest tertile 68 alanine aminotransferase ALT 68 LDL C 68 microalbuminuria 68 normotensive 68 #.#/#.# mmHg [001] 68 fasting triglyceride levels 68 hypertensives 67 #mmHg [001] 67 nonfasting triglyceride levels 67 cardiovascular mortality 67 antihypertensive therapy 67 serum urate levels 67 β blockers 67 EDSS scores 67 hsCRP levels 67 MADRS score 67 NATRECOR R 67 proteinuria 67 diastolic BP 67 insulin glargine 67 detemir 67 serum phosphate 67 metabolic parameters 67 glomerular filtration rate 67 lumbar spine BMD 67 biphasic insulin aspart 67 OADs 67 virologic failure 67 eGFR 67 creatinine levels 67 pCR 67 glycosylated hemoglobin levels 67 #mmHg [002] 67 HBeAg seroconversion 67 CrCl 67 rimonabant #mg 67 PASI scores 67 intima media thickness 67 plasma glucose levels 66 plasma glucose 66 albumin excretion 66 pioglitazone 66 serum calcium 66 oral antidiabetic medication 66 mmHg 66 ATACAND 66 dapagliflozin plus 66 mm Hg systolic 66 adjunctive placebo 66 serum concentrations 66 LDL cholesterol levels 66 T2DM 66 systolic blood pressure 66 hemoglobin concentrations 66 carotid IMT 66 PSADT 66 serum phosphate levels 66 postprandial glucose 66 corticosteroid dose 66 elevated LDL cholesterol 66 lipid levels 66 MMSE score 66 #.#mmol L [002] 66 recurrent VTE 66 virologic response 66 sustained virologic response 66 oxycodone CR 66 nonfatal MI 66 mm Hg 66 Hb A1c 66 glargine 66 poor metabolizers 66 ejection fractions 66 blood Phe levels 65 Triglyceride levels 65 hypoglycemic events 65 neutrophil counts 65 primary hypercholesterolemia 65 arterial stiffness 65 serum sodium 65 atherogenic dyslipidemia 65 serum cholesterol 65 plasma HCV RNA 65 BENICAR HCT 65 serum IGF 65 % Confidence Interval 65 subclinical hypothyroidism 65 APTIVUS r 65 serum testosterone 65 virological response 65 Score DAS# 65 transaminase levels 65 urate levels 65 lipid lowering medications 65 undetectable HCV RNA 65 postoperative mortality 65 hypertensive patients 65 incontinence episodes 65 liver histology 65 CLA supplementation 65 SHBG levels 65 mmHg diastolic 65 achieved statistical significance 65 gout flares 65 systolic dysfunction 65 serum lipid levels 65 carotid intima media 65 candesartan 65 QTcF 65 tirofiban 65 binary restenosis 65 HbA 1C 64 hydroxyvitamin D levels 64 lipid lowering therapy 64 antihypertensive drugs 64 #mg/day [001] 64 mealtime insulin 64 nicardipine 64 leukocyte count 64 DCCT 64 creatinine clearance 64 #mg/dL [002] 64 Crohn Disease Activity 64 MetS 64 statin therapy 64 elevated ALT 64 microvascular complications 64 glycemic control 64 tapentadol ER 64 Lantus ® 64 asymptomatic carotid stenosis 64 annualized relapse 64 plasma uric acid 64 nocturnal hypoglycaemia 64 troponin T 64 nondepressed 64 plasma triglycerides 64 certolizumab 64 OGTT 64 advanced adenomas 64 elevated triglyceride levels 64 serum vitamin D 64 NIHSS score 64 EDSS score 64 postintervention 64 unfractionated heparin 64 hip BMD 64 serum PSA 64 tiotropium 64 -#.# mg dL [002] 64 depressive symptoms 64 NYHA functional class 64 A1Cs 64 #mg/dL [001] 64 triglyceride concentrations 64 systolic hypertension 64 irbesartan 64 triglyceride concentration 64 mmHg systolic 64 sitagliptin 64 tHcy 64 triacylglycerol concentrations 64 serum HCV RNA 64 creatinine ratio 64 definite stent thrombosis 64 PREZISTA r 64 atazanavir ritonavir 64 hyperglycaemia 64 lipid lowering drugs 64 adiponectin levels 64 BENICAR 64 mIU L 64 severe exacerbations 64 g dL 64 CVD mortality 63 retinal thickness 63 eplerenone 63 lipid parameters 63 Fasting plasma glucose 63 inadequate glycemic 63 laboratory abnormalities 63 magnesium intake 63 alanine aminotransferase 63 moderate renal impairment 63 glimepiride 63 lipid profiles 63 median PFS 63 ziprasidone 63 fosamprenavir 63 Baseline characteristics 63 aminotransferase levels 63 oral antidiabetes 63 serum triglyceride levels 63 adalimumab 63 blood glucose concentrations 63 CDAI score 63 homocysteine levels 63 biochemical recurrence 63 pramlintide 63 lipid lowering agents 63 pulmonary capillary wedge 63 mmol L 63 aspartate aminotransferase AST 63 colorectal adenoma 63 thiazide diuretics 63 glucose lowering 63 mEq L 63 tolvaptan 63 Ishak fibrosis score 63 diabetes mellitus 63 serum triglycerides 63 μmol L 63 prospectively defined 63 symptomatic VTE 63 undetectable viral load 63 lopinavir r arm 63 NYHA class 63 cardiovascular morbidity 63 extrapyramidal symptoms 63 albuminuria 63 ejection fraction 63 paricalcitol 63 severe hypoglycemia 63 mg kg dose 63 nondiabetic 63 sustained virological response 63 #mg doses [002] 63 NNT = 63 sinus rhythm 63 mg QD 63 subcutaneous insulin 63 acarbose 63 highest tertile 63 hsCRP 63 uric acid levels 63 CCyR 63 insulin lispro 63 PSA nadir 63 metformin monotherapy 63 undetectable viral 63 LEXIVA r 63 timepoints 63 apnea hypopnea index 63 serum glucose 63 thyrotropin levels 63 #/#mmHg 63 XIENCE V PROMUS Stent 63 urate lowering therapy 63 ng dL 63 QTc 63 antihypertensive medication 63 mg dl 63 CC genotype 63 improves glycemic 63 aripiprazole 63 nonvertebral fractures 63 NIHSS 63 mg BID 62 olmesartan 62 mg d 62 preintervention 62 valsartan 62 comorbid conditions 62 tertile 62 HCV RNA 62 FEV1 62 nondiabetics 62 mg simvastatin 62 p = .# [002] 62 #.#mg/dL 62 serum folate 62 atorvastatin #mg 62 complete cytogenetic response 62 severe renal impairment 62 statin monotherapy 62 urine albumin 62 hypoglycemic episodes 62 serum clusterin levels 62 serum PTH 62 x ULN 62 aminotransferases 62 peginterferon alfa 2a 62 IBS symptoms 62 abacavir lamivudine 62 homocysteine concentrations 62 LANTUS R 62 CR nPR 62 Fasting glucose 62 Hb levels 62 virological failure 62 hours postdose 62 albumin excretion rate 62 adenoma recurrence 62 mg dose 62 left ventricular dysfunction 62 pg mL 62 P = .# 62 viral load 62 symptomatic intracerebral hemorrhage 62 elevated creatinine 62 beta blocker therapy 62 FOLFOX4 62 dose colchicine 62 solifenacin 62 prolactin levels 62 macroalbuminuria 62 morphometric vertebral fractures 62 impaired fasting glucose 62 mucosal healing 62 glomerular filtration 62 Index CDAI score 62 reinfarction 62 titrated glipizide 62 overt nephropathy 62 log# copies mL 62 dose atorvastatin 62 secondary efficacy endpoints 62 blood Phe 62 hyperglycemia 62 infarct size 62 pg ml 62 hemoglobin concentration 62 mU L 62 HDL C 62 divalproex sodium 62 systolic blood pressures 62 insulin degludec 62 TEAEs 62 active comparator 62 mmol L. 62 CI -#.# 62 Hemoglobin A1c 62 cardiorespiratory fitness 62 oral antidiabetic drugs 62 HBeAg negative patients 62 nonobese 62 biochemical relapse 62 octreotide LAR 62 advanced adenoma 62 YMRS 62 lung function 62 estimated GFR 62 serum potassium levels 62 CHD mortality 62 renal dysfunction 62 metformin sulphonylurea 62 cardiometabolic risk 62 clodronate 62 #mg/day [002] 62 ruboxistaurin 62 urinary albumin 62 posttransplant 62 chlorambucil 62 Montgomery Asberg Depression 62 serum HBV DNA 62 prescribed statins 62 HBV DNA levels 62 g dl 62 diastolic blood pressures 62 adjunctive ABILIFY 62 achieved ACR# 62 blood glucose 62 % CI #.#-#.# [003] 62 p = NS 62 mcg kg 62 intensive statin therapy 62 DAPT 62 bezafibrate 62 elevated triglycerides 62 concomitant medications 61 coronary revascularization 61 endoscopic remission 61 Primary endpoints 61 statistical significance p 61 peginterferon 61 glulisine 61 severe hypoglycaemia 61 #mg dose [002] 61 allopurinol 61 Unified Parkinson Disease 61 nonsignificant 61 systolic 61 μg dL 61 exhaled NO 61 serum creatinine 61 quetiapine 61 LPV r 61 arterial thromboembolic events 61 desvenlafaxine succinate 61 ARB telmisartan 61 placebo p = 61 Kaplan Meier analysis 61 sUA levels 61 #mg dose [003] 61 isolated systolic hypertension 61 μg kg 61 nmol L 61 carotid stenosis 61 mm Hg diastolic 61 IU mL 61 iPTH 61 ADAS Cog 61 symptom severity 61 ADAS cog 61 QTc prolongation 61 atheroma volume 61 candesartan cilexetil 61 metformin sulfonylurea 61 + PH# 61 left ventricular ejection 61 apolipoprotein B 61 Elitek 61 inflammatory biomarkers 61 mean baseline A1C 61 HBV DNA 61 diabetes mellitus DM 61 dose titration 61 metformin 61 oral glucose tolerance 61 LV dysfunction 61 left ventricular systolic 61 serum phosphorous 61 posttreatment 61 copies mL 61 #.#mmHg 61 estimated glomerular filtration 61 flutamide 61 periprocedural 61 cerebrovascular events 61 VADT 61 mg ustekinumab 61 Lucentis monotherapy 61 anticoagulation 61 DAS# scores 61 rosuvastatin 61 hypokalemia 61 MACCE 61 colorectal neoplasia 61 dosage regimens 61 RLS symptoms 61 tipranavir r 61 RLAI 61 ramipril 61 intact parathyroid hormone 61 placebo 61 macrovascular 61 REYATAZ r arm 61 attain statistical significance 61 umol L 61 lumbar spine bone 61 baseline serum creatinine 61 CK # plasma concentrations 61 clinically meaningful improvements 61 bosentan 61 #.#mmol L [001] 61 conventional antipsychotics 61 TAXUS Express Stent 61 placebo dexamethasone 61 mg BID dose 61 antidiabetic medication 61 hippocampal volume 61 rosuvastatin #mg 61 fructose diet 61 tamsulosin 61 antiarrhythmic drug 61 endometrial thickness 61 HAQ DI 61 Apidra ® 61 peginterferon alfa 2b 61 glyburide 61 dose clopidogrel 61 MELD scores 61 ONGLYZA 61 timepoint 60 macrovascular disease 60 eptifibatide 60 dalteparin 60 hypogonadal men 60 β blocker 60 pulmonary exacerbations 60 onset diabetes mellitus 60 Index CDAI 60 DAS# [002] 60 serum aminotransferase levels 60 impaired glucose tolerance 60 dose cohort 60 tHcy concentrations 60 everolimus eluting stents 60 CD4 + cell 60 renal function 60 mg/m2 dose 60 postprandial blood glucose 60 low dose Iluvien 60 Cmax 60 fluticasone salmeterol 60 serum sodium levels 60 Ramipril 60 aldosterone antagonist 60 adenotonsillectomy 60 ACE inhibitor ramipril 60 reach statistical significance 60 resistant hypertension 60 confidence interval #.#-#.# 60 mg TID 60 vertebral fracture 60 #mg/dl 60 lopinavir r 60 prespecified 60 benazepril 60 transferrin saturation 60 mIU ml 60 mL/min/#.# m2 60 p = #.# [003] 60 ipsilateral stroke 60 polyp recurrence 60 MS relapses 60 sulfonylurea 60 % CI #.#-#.# [006] 60 atherothrombotic events 60 Insulin sensitivity 60 lamivudine monotherapy 60 5-FU/LV 60 serum phosphorus levels 60 lymphocyte count 60 NNRTI resistance 60 ACTEMRA TM 60 GERD symptoms 60 hyperphenylalaninemia HPA due 60 CIMZIA ™ 60 losartan 60 DASH diet 60 CPAP adherence 60 progression TTP 60 gastric pH 60 AZOR 60 HAM D# scores 60 lamotrigine 60 femoral neck BMD 60 mesalamine granules 60 ritonavir boosted 60 adiponectin concentrations 60 renal impairment 60 warfarin therapy 60 HIV RNA 60 diuretic chlorthalidone 60 methotrexate monotherapy 60 CK MB 60 hs CRP 60 macrovascular events 60 T1DM 60 relapsed MM 60 subclinical atherosclerosis 60 4mg/kg 60 Montgomery Åsberg Depression 60 NovoLog ® Mix 60 complete cytogenetic 60 reflux symptoms 60 COPAXONE R 60 #.#ng/ml 60 prednisone prednisolone 60 Apgar scores 60 UACR 60 subclinical hyperthyroidism 60 hemoglobin levels 60 SUVmax 60 elevated serum creatinine 60 chlorthalidone 60 oral allopurinol 60 CI #.#-#.# [001] 60 transaminases 60 % CI #.#-#.# [007] 60 platelet inhibition 60 mcg QD 60 antibody titer 60 D dimer 60 peak VO2 60 cardiovascular hospitalizations 60 ACR# response 60 nocturnal awakenings 60 urinary oxalate 60 donepezil 60 angiographic outcomes 60 aminotransferase elevations greater 60 salivary cortisol 60 multivariable analysis 60 C reactive protein 60 mean baseline HbA1c 60 paclitaxel eluting stents 60 oral antidiabetic medications 60 ADCS ADL 60 systemic embolism 60 rapid virologic response 60 montelukast 60 primary generalized tonic 60 lispro alone 60 venlafaxine XR 60 intraocular pressure 60 cTnT levels 60 tolterodine ER 60 PRADAXA 60 triglycerides 60 Pioglitazone 60 LEXIVA 60 log# IU mL 60 orthostatic hypotension 60 postdischarge 60 postop 60 thickness CIMT 60 diameter stenosis 60 flow mediated dilation 60 serum CRP 60 d dimer 60 HDRS 60 calculated creatinine clearance 60 ADHD symptoms 60 cilostazol 60 renal insufficiency 60 placebo fluoxetine 60 tertiles 60 glucose tolerance 60 GH deficiency 60 HIV HCV coinfected 60 KRAS mutations occur 60 serum estradiol 60 plasma glucose concentration 60 asthma exacerbations 60 plus methotrexate 60 detectable HCV RNA 60 prehypertension 60 -#.# log# 60 diastolic pressure 60 inhaled steroid 60 dose statin therapy 60 gliclazide 60 ABC/3TC 60 mg doses 59 serum retinol 59 evaluable subjects 59 per deciliter mg 59 intraocular pressure IOP 59 canakinumab 59 NATRECOR ® 59 UKPDS 59 EXJADE 59 cholesterol LDL C 59 fluvastatin 59 oral hypoglycemic agent 59 urinary albumin excretion 59 PREZISTA r arm 59 euthyroid 59 lactate dehydrogenase LDH 59 concomitant AEDs 59 antidiabetic medications 59 ALT elevations 59 recurrent venous thromboembolism 59 elevated IOP 59 Median survival 59 nocturnal hypoglycemia 59 ULORIC 59 Visual acuity 59 renal artery stenosis 59 acute gout flares 59 Ejection Fraction 59 experienced virologic failure 59 pentoxifylline 59 placebo p 59 #mg dose [001] 59 androgen suppression 59 SCr 59 epoetin alfa 59 Scale EDSS 59 LDL cholesterol 59 elevated fasting glucose 59 elevated CRP 59 abciximab 59 azacitidine 59 PANSS scores 59 fraction LVEF 59 CD4 cell 59 IRLS score 59 EDARBI 59 transaminase elevations 59 revascularizations 59 baseline LDH 59 diastolic blood pressure 59 TAXUS Stent 59 glipizide 59 blood phenylalanine Phe 59 salmeterol fluticasone 59 angiographic restenosis 59 TMC# r 59 TT genotype 59 undetectable HBV DNA 59 oral diclofenac 59 trials RCTs 59 patients undergoing CABG 59 mmol liter 59 mcg BID 59 #mg QD [001] 59 olanzapine 59 stable angina 59 Expanded Disability Status 59 nonadherence 59 prior chemotherapy regimens 59 sulphonylurea 59 pyridostigmine 59 revascularization procedures 59 hypoglycemia 59 lymphocyte counts 59 FOLPI 59 noninferiority 59 postoperative complication 59 CDAI 59 esomeprazole 59 Lantus R 59 comorbidities 59 levosimendan 59 serum magnesium 59 glycemic variability 59 cystatin C 59 dyslipidaemia 59 confidence interval CI 59 SGRQ 59 comparator arm 59 calcium supplementation 59 Psoriasis Area 59 ALT flares 59 plasma homocysteine 59 vildagliptin 59 UPDRS scores 59 colesevelam HCl 59 plasma folate 59 exhaled nitric oxide 59 teriflunomide 59 dexmedetomidine 59 severe hypoglycemic 59 density lipoprotein cholesterol 59 coadministration 59 generalized edema 59 postoperative AF 59 RBP4 levels 59 FDA defined valvulopathy 59 lopinavir ritonavir 59 BMI z 59 obese adolescents 59 Cardiovascular Risk 59 elevated LDL 59 plasma homocysteine levels 59 Pred Forte 59 viral suppression 59 ARIXTRA 59 Negative Syndrome 59 lymphocytosis 59 secondary endpoint 59 ETDRS 59 receiving VICTRELIS 59 CIMZIA TM 59 unfractionated heparin UFH 59 clinically meaningful improvement 59 thromboembolic events 59 mineral density 59 urinary excretion 59 autoantibody levels 59 nonobstructive CAD 59 serum ALT 59 acute STEMI 59 serum homocysteine 59 nmol l 59 plasma renin activity 59 statistically significant p = 59 hematologic toxicity 59 lanthanum carbonate 59 serum cortisol 59 diastolic pressures 59 hypomagnesemia 59 creatinine 59 composite endpoint 59 IFN α 59 Doxil ® 59 NSTE ACS 59 QTc intervals 59 leukopenia 59 hyperuricemia 59 thyroid hormone levels 59 International Normalized Ratio 59 serum folate concentrations 59 hypoglycaemic episodes 59 secondary efficacy endpoint 59 azathioprine 59 BARACLUDE ® 59 fondaparinux 59 kidney function 59 enoxaparin 59 depressive symptomatology 59 FOSRENOL ® 59 angiotensin II receptor blockers 59 eosinophil count 59 NHANES III 59 Flu Cy 59 hydroxychloroquine 59 molindone 59 telomere lengths 59 plasma concentrations 59 Scale EDSS score 59 IFN beta 59 antihypertensive agents 59 sunitinib 59 PRADAXA #mg 59 blood sugar 59 citalopram 59 Secondary endpoints 59 ALT elevation 59 CRESTOR #mg 59 #.#mmol l [002] 59 uncontrolled asthma 59 TDF FTC 59 -#.# mmol L 59 ancrod 59 Victoza R 59 RYGB 59 hypophosphatemia 59 GnRH agonist 59 coronary artery calcification 59 mcg mL 59 seroprotection 58 nmol liter 58 HBeAg 58 genotypic resistance 58 alteplase 58 tumor histology 58 receiving Vectibix monotherapy 58 STRIDE PD 58 cotinine levels 58 nonfatal stroke 58 clomipramine 58 free survival PFS 58 #mg BID [001] 58 adrenal function 58 urinary N telopeptide 58 hyperkalemia 58 risperidone Risperdal 58 liraglutide 58 diastolic function 58 cinacalcet 58 IIIa inhibitors 58 spontaneous preterm delivery 58 serum LDL cholesterol 58 p = #.# [002] 58 HSCT 58 hepatic insulin sensitivity 58 plus MTX 58 hypoglycaemia 58 idraparinux 58 ACTOplus met 58 Rating Scale MADRS 58 insulin sensitivity 58 hypertension 58 ADCS CGIC 58 ng mL 58 dose cohorts 58 index BMI 58 Welchol 58 antidepressant therapy 58 pravastatin 58 CD4 counts 58 #.#/#.# mm Hg [003] 58 oral antidiabetic agents 58 neurologic progression 58 pmol L 58 PaO 2 58 systemic corticosteroids 58 coronary calcification 58 double blinded placebo 58 p = #.# [004] 58 acromegalic patients 58 folate supplementation 58 QRS duration 58 SSRI citalopram 58 Operative mortality 58 IOP lowering 58 lipid abnormalities 58 RBP4 58 ADHD RS 58 corrected QT interval 58 telmisartan 58 titrated 58 HBeAg positive patients 58 mean serum phosphorus 58 typical antipsychotics 58 HAART regimen 58 clinically meaningful reductions 58 ARCOXIA 58 paroxysmal AF 58 Secondary efficacy endpoints 58 8mg/kg 58 Complication rates 58 statistically nonsignificant 58 dietary intake 58 clopidogrel 58 diastolic heart 58 QIDS SR 58 FeNO 58 dosing cohort 58 IPSS 58 tipranavir ritonavir 58 Score IPSS 58 anemia hemoglobin 58 μg L 58 IDDM 58 venlafaxine Effexor 58 normal ULN 58 epoetin 58 Medication adherence 58 post prandial glucose 58 HBeAg positive 58 Engerix B 58 primary efficacy endpoints 58 neurodevelopmental impairment 58 premenopausal 58 sulphonylureas 58 NT proBNP 58 lipid lowering medication 58 subscore 58 arterial thickening 58 protein excretion 58 HER2 expression 58 prescribed beta blocker 58 periprocedural MI 58 glycaemia 58 elevated uric acid 58 serum leptin 58 blood lipids 58 virologic suppression 58 VIAject ™ 58 quetiapine risperidone 58 lamivudine refractory patients 58 nonvertebral fracture 58 statistically significant p 58 gm dl 58 AVODART 58 sweat chloride 58 intravenous diuretics 58 repeat revascularization 58 imatinib therapy 58 doxazosin 58 folate intake 58 Cypher Stent 58 COPD exacerbation

Back to home page